Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvsef exchanges : Amex save search
Atopic Dermatitis Drugs Market to grow by USD 4.7 billion from 2022-2027 | North America to account for 36% of market growth- Technavio
Published: 2023-10-17 (Crawled : 05:00) - prnewswire.com
ALPMY | $9.47 520K
|
Manufacturing
|
| O: -0.27%
H: 1.38%
C: 0.83%
VTRS | $11.23 0.99% 1.5M
|
Health Technology
|
| O: -0.95%
H: 1.81%
C: 0.53%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.2%
H: 0.44%
C: -0.56%
ABBV | News | $166.43 1.08% 2M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
PHGE | News | $0.2897 -2.06% 30K
|
Health Technology
|
| O: 5.0%
H: 3.17%
C: -1.56%
america dermatitis market
The Worldwide Diabetic Retinopathy Industry is Expected to Reach $7.7 Billion by 2027 at a 11.3% CAGR
Published: 2022-11-22 (Crawled : 13:00) - prnewswire.com
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: 0.33%
H: 1.88%
C: 1.53%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.77%
H: 0.41%
C: 0.27%
REGN | $894.71 0.08% 180K
|
Health Technology
|
| O: 0.66%
H: 0.79%
C: 0.72%
ALIM | $3.46 0.58% 29K
|
Health Technology
|
| O: 0.47%
H: 7.5%
C: -1.17%
expected diabetic
Worldwide Radiotheranostics Industry to 2027 - By Radioisotope, Application, End-user, Competitive Landscape and Region
Published: 2022-11-09 (Crawled : 20:00) - prnewswire.com
TRUMF | $16.928 1.9K
|
Health Technology
|
| O: 2.88%
H: 1.93%
C: -0.99%
TRUMY | $16.507 34K
|
Manufacturing
|
| O: 0.27%
H: 3.27%
C: 3.27%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 2.81%
H: 0.43%
C: -0.2%
BSX | $67.235 -0.27% 3.7M
|
Health Technology
|
| O: 3.26%
H: 1.01%
C: 0.76%
YMAB | $14.955 -0.3% 120K
|
Health Technology
|
| O: 4.96%
H: 9.22%
C: 9.22%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 5.57%
H: 9.88%
C: 7.49%
ATNM | $6.695 0.38% 130K
|
Health Technology
|
| O: 3.4%
H: 3.63%
C: 2.25%
Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT2606, a Proposed Biosimilar of Nucala® (mepolizumab) Bio-Thera Solutions, Ltd. announced that dosing has begun in a Phase I cli...
Published: 2022-10-14 (Crawled : 13:00) - biospace.com/
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.17%
H: 0.8%
C: -0.75%
MS | News 0 d | $91.34 1.2% 2.9M
|
Finance
|
| O: -2.63%
H: 2.37%
C: -2.5%
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 1.93%
H: 0.0%
C: 0.0%
DVA | $127.84 1.37% 140K
|
Health Services
|
| O: 0.65%
H: 1.88%
C: -0.77%
VRNA | $15.66 -2.73% 190K
|
Health Technology
|
| O: 0.4%
H: 1.39%
C: -0.3%
UTHR | $235.85 -0.46% 120K
|
Health Technology
|
| O: 0.24%
H: 1.71%
C: 1.01%
NNVC | $1.1 -6.38% 12K
|
Health Technology
|
| O: 2.34%
H: 0.0%
C: 0.0%
bat2606 nucala solutions biosimilar study
Head and Neck Cancer Market worth $ 9.07 Billion by 2030 - Exclusive Report by InsightAce Analytic
Published: 2022-03-23 (Crawled : 11:00) - prnewswire.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 3.81%
H: 0.0%
C: -0.44%
AZNCF | $138.24 800
|
Health Technology
|
| O: -4.55%
H: 6.28%
C: 6.28%
PFE A | $25.81 1.65% 15M
|
Health Technology
|
| O: -1.94%
H: 0.0%
C: 0.0%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: -0.87%
H: 0.0%
C: 0.0%
BMY | $48.58 0.58% 2.6M
|
Health Technology
|
| O: -0.55%
H: 0.0%
C: 0.0%
MGNX | $15.42 -4.05% 240K
|
Health Technology
|
| O: -1.31%
H: 3.88%
C: -0.67%
KURA | $17.15 -3.0% 460K
|
Health Technology
|
| O: -1.34%
H: 0.12%
C: -2.6%
INCY | $52.45 -0.7% 530K
|
Health Technology
|
| O: 0.04%
H: 0.08%
C: -1.26%
AZN | $68.3 -0.09% 2M
|
Health Technology
|
| O: -0.31%
H: 1.85%
C: 1.55%
ADXS | $0.57 9.5K
|
Health Technology
|
| O: -1.64%
H: 8.33%
C: 0.0%
CVM | $1.51 0.67% 48K
|
Health Technology
|
| O: -0.92%
H: 2.31%
C: -3.47%
report cancer market
AavantiBio Announces Formation of Scientific Advisory Board
Published: 2022-02-09 (Crawled : 14:00) - biospace.com/
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
NVS | $93.81 1.34% 1.2M
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
IBIO | $1.771 0.06% 42K
|
Health Technology
|
| O: 2.98%
H: 0.0%
C: 0.0%
ces
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.054 50.0% 290M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
INSG | $2.98 23.14% 190K
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.